News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

All-Stars in Pathology Informatics and Clinical Laboratory Information Systems Gather in Pittsburgh to Assess Market Changes

Pathology profession’s leading experts in lab informatics predict plenty of disruption as hospitals work to integrate their informatics systems

DATELINE—PITTSBURGH, PENNSYLVANIA: Last Friday, what I will call the All-Stars of pathology informatics and clinical laboratory information systems (LIS) came together for a one-day Strategy Summit. Disruptive forces are loose within the laboratory informatics space and participants were eager to understand these trends and develop effective responses to keep medical laboratory testing at the forefront of clinical care.

Almost 100 pathologists, laboratory informatics vendors, LIS consultants, and hospital CIOs participated. Your Dark Daily editor was here as a careful listener. The Strategy Summit was organized by the Association for Pathology Informatics (API). API President Mark Tuthill, M.D., was chair of the program. Tuthill is also Division Head, Pathology Informatics, at Henry Ford Health System in Detroit, Michigan. (more…)

Why Health Insurers Want to Pre-Authorize Genetic and Expensive Clinical Pathology Lab Tests

McKesson Corp. and MuirLab working to implement lab-friendly strategies to meet payer needs

Unfolding events make it likely that genetic testing will become a good news/bad news story for local clinical laboratories and pathology groups. The good news is that genetic tests and molecular assays will bring more diagnostic precision to patients and their physicians—and that points to an auspicious future for pathology and laboratory medicine.

The bad news is that payer requirements in the United States for pre-authorization of genetic tests may lock-out most local laboratories as providers for these specialized and important clinical laboratory tests. That’s the irony of this developing trend!

(more…)

;